Public Policy

Worthy Initiative Proposes Bold Federal Healthcare Reforms
Public Policy Worthy Initiative Proposes Bold Federal Healthcare Reforms

The American healthcare system is currently facing a crisis of affordability and efficiency, characterized by rising costs and a fragmented delivery model that often prioritizes volume over value. Faisal Zain, a prominent healthcare expert specializing in medical technology and device innovation,

Can Life Biosciences Reverse Human Aging Through the Eye?
Public Policy Can Life Biosciences Reverse Human Aging Through the Eye?

Modern medicine is finally moving beyond the passive management of decline, attempting instead to fundamentally rewrite the biological scripts that dictate how and when our bodies fail. The biotechnology landscape is currently undergoing a seismic shift, moving beyond traditional symptom management

Why Is American Healthcare So Expensive and Inefficient?
Public Policy Why Is American Healthcare So Expensive and Inefficient?

The United States continues to hold the dubious distinction of spending more on medical services than any other nation on Earth while simultaneously recording some of the lowest life expectancy rates in the developed world. This fiscal trajectory, characterized by a multi-trillion dollar annual

Are Compounded GLP-1 Drugs Safe for Weight Loss?
Public Policy Are Compounded GLP-1 Drugs Safe for Weight Loss?

Faisal Zain is a distinguished expert in medical technology and healthcare regulation, bringing years of specialized experience in the manufacturing of diagnostic and treatment devices. Throughout his career, he has been a vocal advocate for innovation that prioritizes patient safety and rigorous

Hospice Alliance Urges CMS to Target Fraud With CRUSH Rule
Public Policy Hospice Alliance Urges CMS to Target Fraud With CRUSH Rule

The sanctity of end-of-life care is currently facing an unprecedented challenge as criminal networks attempt to siphon billions from the federal programs designed to support the most vulnerable Americans. As the hospice sector expands to meet the needs of an aging population, the tension between

FDA Expands Wegovy Label to Include Heart Disease Risk Reduction
Public Policy FDA Expands Wegovy Label to Include Heart Disease Risk Reduction

The pharmaceutical landscape is currently witnessing a historic pivot as the distinction between metabolic maintenance and life-saving cardiovascular intervention begins to evaporate entirely. For decades, the medical community viewed weight-loss medications through a narrow lens of aesthetic

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later